Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ACP3 | P15309 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24967234 | 0.85 | RIPK1 (0.38) | DPP4TSHRF2ALDH1A1TAAR1 | |
| SCHEMBL24967871 | 0.85 | RIPK1 (0.38) | DPP4TSHRF2ALDH1A1TAAR1 | |
| SCHEMBL22668636 | 0.85 | RIPK1 (0.38) | DPP4TSHRF2ALDH1A1TAAR1 | |
| SCHEMBL7647445 | 0.84 | ESR1 (0.46) | — | |
| Phenol SCHEMBL30580405 | 0.81 | ESR1 (0.58) | ALDH1A1IDO1TDO2 | |
| SCHEMBL7582959 | 0.80 | PGK1 (0.38) | TSHRACP3IDO1TDO2 | |
| SCHEMBL22624200 | 0.79 | LMNA (0.39) | HTR2ATAAR1 | |
| SCHEMBL29010088 | 0.79 | CYP2D6 (0.41) | ACP3CYP2D6SRC | |
| SCHEMBL10069117 | 0.77 | ESR1 (0.59) | DPP4TSHRF2ALDH1A1HTR2A | |
| SCHEMBL7772037 | 0.74 | DPP4 (0.39) | DPP4TSHRF2ALDH1A1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2023-10-10 | — | — | US | claimed |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI, INC. (US) | 2022-02-03 | — | — | US | claimed |
| EP-3019510-B1 | USE OF IMMOBILIZED MOLYBDEN- UND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | VERBIO VER BIOENERGIE AG (DE) | 2020-12-02 | — | — | EP | claimed |
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | claimed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | claimed |
| EP-3377465-A2 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | Provivi, Inc. (US) | 2018-09-26 | — | — | EP | claimed |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | XIMO AG (CH) | 2018-09-11 | — | — | US | claimed |
| US-20160159727-A1 | USE OF IMMOBILIZED MOLYBDENUM- AND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | VERBIO SE (DE) | 2016-06-09 | — | — | US | claimed |
| EP-3019510-A1 | USE OF IMMOBILIZED MOLYBDEN- UND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | XiMo AG (CH) | 2016-05-18 | — | — | EP | claimed |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2016-02-04 | — | — | US | claimed |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | VERBIO SE (DE) | 2014-10-16 | — | — | US | claimed |
| WO-2014139679-A2 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | XIMO AG (CH) | 2014-09-18 | — | — | WO | claimed |
| EP-2703081-A1 | Molybdenum and tungsten complexes as olefin metathesis catalysts and reactions using the catalysts | XiMo AG (CH) | 2014-03-05 | — | — | EP | claimed |
| WO-2012138844-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM-AIR BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2012-10-11 | — | — | WO | claimed |
| US-20110034733-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-10 | — | — | US | claimed |
| US-7737628-B2 | Aromatic amine derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-15 | — | — | US | claimed |
| EP-0866110-B1 | Light-emitting material for organo-electroluminescence device and organic electroluminescence device | TOYO INK MFG CO (JP) | 2004-10-20 | — | — | EP | claimed |
| EP-0934992-B1 | Light-emitting material for organo-electroluminescence device and organic electroluminescence device | TOYO INK MFG CO (JP) | 2004-07-21 | — | — | EP | claimed |
| US-6723485-B1 | HEXAFLUOROISOPROPYL (METH)ACRYLATE RESIN AND PHOTOACID GENERATOR; LASER HAVING WAVELENGTH IN VACUUM ULTRAVIOLET REGION | CENTRAL GLASS COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | claimed |
| EP-1103856-A1 | Positive resist composition & process for forming resist pattern using same | Central Glass Company, Limited (JP) | 2001-05-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | DPP4 3604/4885TSHR 4219/4885F2 237/4885 |
| US-20140309466-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, PYM1, SQLE | DPP4 4506/4885TSHR 2482/4885F2 156/4885 |
| US-20160030936-A1 | METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | MSMO1, SQLE, PYM1 | DPP4 4528/4885TSHR 2403/4885F2 159/4885 |
| US-20110034733-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | TYR, DDC, EML4 | DPP4 2440/4885TSHR 4212/4885F2 2293/4885 |
| US-20160159727-A1 | USE OF IMMOBILIZED MOLYBDENUM- AND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | DUOX1, DUOX2, MSN | DPP4 4756/4885TSHR 4162/4885F2 746/4885 |
| US-11779911-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | DPP4 4229/4885TSHR 1977/4885F2 2/4885 |
| US-20220032280-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | SREBF1, F2, SREBF2 | DPP4 4229/4885TSHR 1977/4885F2 2/4885 |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | DUOX1, DUOX2, MSN | DPP4 4756/4885TSHR 4162/4885F2 746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.